Content about AstraZeneca

June 28, 2010
Generic drug makers launch anastrozole tablets

The Food and Drug Administration has approved two new generic versions of a drug for...

June 21, 2010
Bristol-Myers Squibb, AstraZeneca: Dapagliflozin meets trial endpoints

An investigational drug used by Type 2 diabetes treatment-naive adult patients showed statistically significant reductions...

June 21, 2010
Hospira gets FDA nod for generic Merrem

The Food and Drug Administration has approved a generic, injectable antibiotic....

June 9, 2010
Dr. Reddy's gets tentative approval for asthma drug

The Food and Drug Administration has given tentative approval to Dr. Reddy’s Labs for a...

June 6, 2010
FDA takes a stand against misleading drug ads

From sophisticated computer-generated animation to camera work worthy of Hollywood to celebrity endorsements, direct-to-consumer drug...

May 31, 2010
AstraZeneca recognized for eco-leadership

AstraZeneca has been awarded for its commitment to environmental sustainability practices....

May 25, 2010
Pfizer names new worldwide R&D president

Pfizer has named Mikael Dolsten as its president for worldwide research and development, the drug...

May 24, 2010
AstraZeneca develops Path to Employment program with local nonprofit group

Anglo-Swedish drug maker AstraZeneca and a local nonprofit group in Wilmington, Del., are combining efforts...

May 24, 2010
FDA: Prolonged PPI use may increase risk of bone fractures

Prolonged use of a common class of drugs for treating digestive problems may increase the...

SILVER SPRING, Md. Prolonged use of a common class of drugs for treating digestive problems may increase the risk of bone fractures, the Food and Drug Administration said Tuesday.

The FDA issued a warning to consumers and healthcare professionals based on a review of several epidemiological studies that long-term use of prescription and OTC proton-pump inhibitors or use of the drugs in high doses could increase the risk of fractures of the hip, wrist and spine. Information about the possible risks will be included on revised product labels for PPIs, the FDA said.

May 19, 2010
Asda to sell cancer drugs on 'not-for-profit' basis

A retailer in the United Kingdom said Thursday it would become the first to sell...

May 17, 2010
AstraZeneca allows Teva to market generic Entocort EC

Teva Pharmaceutical Industries and AstraZeneca have reached a settlement that will allow Teva to market...

May 2, 2010
FDA approves Vimovo

The Food and Drug Administration has approved a drug by AstraZeneca and Pozen for treating...

March 30, 2010
AstraZeneca, Rigel get green light for licensing partnership

A licensing agreement between AstraZeneca and Rigel Pharmaceuticals for a rheumatoid arthritis treatment has gone...

March 29, 2010
FDA issues complete response letter to AstraZeneca, Abbott

The Food and Drug Administration has declined to approve an application for a cholesterol drug...

March 17, 2010
AstraZeneca wins Seroquel case

A state judge in New Jersey has ruled in favor of AstraZeneca in the case...

March 17, 2010
PhRMA names new chairman

The Pharmaceutical Research and Manufacturers of America elected Pfizer president and CEO Jeffrey Kindler as...

March 16, 2010
FDA accepts NDA for combined diabetes drug

The Food and Drug Administration has accepted an approval application for a combination pill for...

March 8, 2010
Bristol-Myers Squibb, AstraZeneca announce postmarketing study for Onglyza

Two drug makers hope to find out how well a diabetes drug works in treating...

February 28, 2010
AstraZeneca to buy drugs it developed with Merck

AstraZeneca plans to buy Merck & Co.’s interest in several drug products that the two...

February 23, 2010
Report projects breast cancer drug sales to exceed $1 billion

An investigational drug for treating breast cancer will garner sales of more than $1 billion...

February 16, 2010
Drug makers sign agreement to develop rheumatoid arthritis drug

Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...

February 3, 2010
Pfizer braces for the future, despite stellar sales in 2009

Pfizer had some impressive results in the earnings report it released Wednesday, but the company...

January 12, 2010
Study finds no adverse effect of antipsychotics on blood sugar, cholesterol levels

Despite a warning from the Food and Drug Administration, blood sugar and cholesterol monitoring of...

January 10, 2010
In splintered drug market, industry seeks solutions

If you’re a pharmaceutical manufacturer, wholesaler or retailer, that distinct chill you’ve been feeling at...

January 6, 2010
Teva announces settlement agreements with AstraZeneca

Teva announced Thursday that it has entered into two definitive agreements with AstraZeneca to settle...